Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Spinal muscular atrophy caused by a novel Alu-mediated deletion of exons 2a-5 in SMN1 undetectable with routine genetic testing

I. Jedličková, A. Přistoupilová, L. Nosková, F. Majer, V. Stránecký, H. Hartmannová, K. Hodaňová, H. Trešlová, M. Hýblová, P. Solár, G. Minárik, M. Giertlová, S. Kmoch

. 2020 ; 8 (7) : e1238. [pub] 20200426

Jazyk angličtina Země Spojené státy americké

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020411

BACKGROUND: Spinal muscular atrophy (SMA) is an inherited neuromuscular disease affecting 1 in 8,000 newborns. The majority of patients carry bi-allelic variants in the survival of motor neuron 1 gene (SMN1). SMN1 is located in a duplicated region on chromosome 5q13 that contains Alu elements and is predisposed to genomic rearrangements. Due to the genomic complexity of the SMN region and genetic heterogeneity, approximately 50% of SMA patients remain without genetic diagnosis that is a prerequisite for genetic treatments. In this work we describe the diagnostic odyssey of one SMA patient in whom routine diagnostics identified only a maternal heterozygous SMN1Δ(7-8) deletion. METHODS: We characterized SMN transcripts, assessed SMN protein content in peripheral blood mononuclear cells (PBMC), estimated SMN genes dosage, and mapped genomic rearrangement in the SMN region. RESULTS: We identified an Alu-mediated deletion encompassing exons 2a-5 of SMN1 on the paternal allele and a complete deletion of SMN1 on the maternal allele as the cause of SMA in this patient. CONCLUSION: Alu-mediated rearrangements in SMN1 can escape routine diagnostic testing. Parallel analysis of SMN gene dosage, SMN transcripts, and total SMN protein levels in PBMC can identify genomic rearrangements and should be considered in genetically undefined SMA cases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020411
003      
CZ-PrNML
005      
20221212090315.0
007      
ta
008      
210728s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/mgg3.1238 $2 doi
035    __
$a (PubMed)32337852
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Jedličková, Ivana $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Spinal muscular atrophy caused by a novel Alu-mediated deletion of exons 2a-5 in SMN1 undetectable with routine genetic testing / $c I. Jedličková, A. Přistoupilová, L. Nosková, F. Majer, V. Stránecký, H. Hartmannová, K. Hodaňová, H. Trešlová, M. Hýblová, P. Solár, G. Minárik, M. Giertlová, S. Kmoch
520    9_
$a BACKGROUND: Spinal muscular atrophy (SMA) is an inherited neuromuscular disease affecting 1 in 8,000 newborns. The majority of patients carry bi-allelic variants in the survival of motor neuron 1 gene (SMN1). SMN1 is located in a duplicated region on chromosome 5q13 that contains Alu elements and is predisposed to genomic rearrangements. Due to the genomic complexity of the SMN region and genetic heterogeneity, approximately 50% of SMA patients remain without genetic diagnosis that is a prerequisite for genetic treatments. In this work we describe the diagnostic odyssey of one SMA patient in whom routine diagnostics identified only a maternal heterozygous SMN1Δ(7-8) deletion. METHODS: We characterized SMN transcripts, assessed SMN protein content in peripheral blood mononuclear cells (PBMC), estimated SMN genes dosage, and mapped genomic rearrangement in the SMN region. RESULTS: We identified an Alu-mediated deletion encompassing exons 2a-5 of SMN1 on the paternal allele and a complete deletion of SMN1 on the maternal allele as the cause of SMA in this patient. CONCLUSION: Alu-mediated rearrangements in SMN1 can escape routine diagnostic testing. Parallel analysis of SMN gene dosage, SMN transcripts, and total SMN protein levels in PBMC can identify genomic rearrangements and should be considered in genetically undefined SMA cases.
650    _2
$a elementy Alu $7 D020087
650    _2
$a western blotting $x metody $7 D015153
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    12
$a delece genu $7 D017353
650    _2
$a genetické testování $x metody $7 D005820
650    _2
$a lidé $7 D006801
650    _2
$a leukocyty mononukleární $x metabolismus $7 D007963
650    _2
$a spinální svalová atrofie $x diagnóza $x genetika $7 D009134
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a sekvenční analýza DNA $x metody $7 D017422
650    _2
$a protein přežití motorických neuronů 1 $x genetika $x metabolismus $7 D055533
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Přistoupilová, Anna $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Nosková, Lenka $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Majer, Filip $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Stránecký, Viktor $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hartmannová, Hana $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hodaňová, Kateřina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Trešlová, Helena $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0279684
700    1_
$a Hýblová, Michaela $u Department of Clinical Genetics, Medirex A.S., Kosice, Slovakia
700    1_
$a Solár, Peter $u Department of Medical Biology, Faculty of Medicine, P.J. Safarik University, Kosice, Slovakia
700    1_
$a Minárik, Gabriel $u Department of Clinical Genetics, Medirex A.S., Kosice, Slovakia
700    1_
$a Giertlová, Mária $u Department of Clinical Genetics, Medirex A.S., Kosice, Slovakia
700    1_
$a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00205675 $t Molecular genetics & genomic medicine $x 2324-9269 $g Roč. 8, č. 7 (2020), s. e1238
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32337852 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20221212090313 $b ABA008
999    __
$a ok $b bmc $g 1691061 $s 1140857
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 8 $c 7 $d e1238 $e 20200426 $i 2324-9269 $m Molecular genetics & genomic medicine $n Mol Genet Genomic Med $x MED00205675
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...